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Cells need backward 
motor to move forward
 
ytoplasmic dynein associates with a variety 
of intracellular cargos and pulls them 
toward the minus ends of microubules. But 
this retrograde motor protein is also essential 
for forward cell migration, as Dujardin et al. 
demonstrate on page 1205.
After observing dynein and its associated 
regulatory proteins at the leading edges of 
migrating cells in a monolayer model of wound 
healing, the authors inhibited dynein activity 
at various times to identify its functions. Early 
in cell migration, dynein helps reorganize the 
microtubule cytoskeleton, placing the centro-
some on the leading edge side of the nucleus. 
Once this rearrangement is completed, inhib-
iting dynein does not change the location of 
the centrosome.
The motor protein is still required for 
cell migration even after cytoskeletal re-
arrangement. During migration, dynein 
appears in a diffuse area along the leading 
edge of the cell, where it seems to capture 
the plus ends of microtubules that enter 
the region. It is unclear whether dynein at 
the leading edge is activating lamellipodial 
protrusion or serving a strictly mechanical 
function, but the mechanism might have 
parallels with the action of dynein at the 
kinetochore, where it both pulls on micro-
tubules and participates in mitotic check-
point signaling.
 
 
 
 
C
Dynein (green) at the front 
of the cell helps the cell move.
 
Neural progenitors ﬁnd VEGF attractive
 
lood vessels and neural stem cells can be led to their targets by the 
same factor, say Zhang et al. on page 1375. The factor, vascular 
endothelial growth factor A (VEGF), is known as a major inducer of angio-
genesis. Zhang et al. show that it is also a powerful attractant for immature 
neural progenitor cells. In the developing mammalian brain, it may be 
used when both neural stem cell migration and blood vessel growth must 
head for the same brain region.
The authors purified neural progenitors from the subventricular zones 
of newborn rats, and cultured them in the presence of fibroblast growth 
factor 2 (FGF-2) to prevent them from differentiating. The progenitor 
cells migrate up gradients of VEGF, in a chemotactic response specifically 
mediated by VEGF receptor 2. In cocultures in three-dimensional 
collagen matrices, the progenitors migrate toward VEGF-secreting cells. 
Progenitor cells that are allowed to differentiate into neuron- or glia-
restricted lineages become insensitive to VEGF.
The data suggest that 
VEGF links angiogene-
sis to neurogenesis to 
establish neurogenic 
niches within the devel-
oping brain. Once the 
niches are established 
by immature progeni-
tors, they could act as launching points for migrations by more differentiated 
cells. VEGF and FGF-2 might be useful in treating brain injuries by directing 
transplanted progenitor cells to migrate into damaged areas. 
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Neural progenitors migrate toward VEGF.
 
Death and the shrinking nucleus
 
uring heart disease and stroke, cells deprived of oxygen often die in a 
way that is distinct from caspase-dependent apoptosis. On page 1219, 
Shinzawa and Tsujimoto provide a first look at the molecular basis of this 
poorly understood process, showing that a phospholipase A
 
2
 
 (PLA
 
2
 
) enzyme 
causes the characteristic nuclear shrinkage that accompanies hypoxic cell death.
 Using a novel permeabilized 
cell assay, the authors purified 
a protein that can cause nuclear 
shrinkage and identified it as 
PLA
 
2
 
. Inhibitor studies con-
firmed that PLA
 
2
 
 is essential 
for nuclear shrinkage in caspase-
independent hypoxic cell death. In hypoxic cells, PLA
 
2
 
 activity increases and 
the calcium-independent form of the enzyme accumulates in the nucleus. 
Blocking calcium-independent PLA
 
2
 
 activity prevents both nuclear shrinkage 
and hypoxic cell death.
An increase in PLA
 
2
 
 activity leads to the cleavage of nuclear lamins, which 
could explain how it causes nuclear shrinkage. Since PLA
 
2
 
 cleaves phospholipids, 
it could also contribute to cell death by disrupting mitochondrial and plasma 
membranes, processes the authors now hope to study biochemically. The 
identification of PLA
 
2
 
 as an important mediator of caspase-independent death 
should also help uncover additional components of the pathway, such as the 
regulators of PLA
 
2
 
 activity and translocation.
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PLA2 (right) shrinks nuclei during hypoxic death.
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